PREDICTABLY HUMAN, INC.

DARIEN, CT · Founded 2020 · Medtech · Private

Digitally controlled aerosolized nicotine replacement therapy device for smoking cessation

Claim this profile

Follows are private to you and power your alerts

Updated · predictablyhuman.com

Sector
Medtech
Headquarters
DARIEN, CT
Founded
2020
Latest Form D
$1.3M, Jan 2025
Total capital
$5.7M
Federal grants
$2.6M
3 awards · 2024–2026
Rank in peer group#420 of 538
Private capital raised
$3.1M
2 Form D · last Jan 2025
21 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
2
6 pending · first 2024
Rank in peer group#190 of 538

Capital timeline

202120222023202420252026FEDERAL ↑EQUITY ↓Cumulative $5.7M$400K$1.1M$1.1M1st Form D$1.7M2nd Form D$1.3M
202120222023202420252026FEDERAL ↑EQUITY ↓Cumulative $5.7M$400K$1.1M$1.1M1st Form D$1.7M2nd Form D$1.3M

Latest events

  • Federal grantHealth and Human S · Phase II · Assessment of a Digitally Controlled Aerosolized Nicotine Replacement Therapy$1.1M
  • Federal grantHealth and Human S · Phase II · Assessment of a Digitally Controlled Aerosolized Nicotine Replacement Therapy$1.1M
  • Private capital raisedForm D · SEC · 2nd filing$1.3M
  • Federal grantHealth and Human S · Phase II · Assessment of a Digitally Controlled Aerosolized Nicotine Replacement Therapy$400K
  • Private capital raisedForm D · SEC · 1st filing$1.7M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grantsBelow median
  • Granted patents#190 · top 35%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • James McConeghyExecutive OfficerNamed in SEC Form D filings
  • Joseph PastoreExecutive OfficerNamed in SEC Form D filings
  • Robert GeimanDirectorNamed in SEC Form D filings
  • Robert JacobsExecutive Officer, DirectorNamed in SEC Form D filings
  • William LawlorExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 8
Show all 8 patent records
  • Drug Delivery Systems, Devices, And MethodsMar 17, 2026 · US 12,576,223Granted
  • Addiction Cessation Systems, Devices, And MethodsApr 24, 2025 · Application 18909807Pending
  • Addiction Cessation Systems, Devices, And MethodsOct 15, 2024 · US 12,114,695Granted
  • Systems And Methods For Smoking CessationApplication 63261638Pending
  • Systems And Methods For Smoking CessationApplication 63203324Pending
  • Smoking Cessation Devices And MethodsApplication 63200068Pending
  • Drug Delivery Systems, Devices, And MethodsApplication PCTUS2022037213Pending
  • Systems And Methods For Smoking CessationApplication 63263863Pending
  • Sinopsys Surgical, Inc.Similar federal contract value in Medtech · null in contracts
  • Emet Surgical, Inc.Similar federal contract value in Medtech · null in contracts
  • MYOLYN, LLCSimilar federal contract value in Medtech · null in contracts
  • Embolx, Inc.Similar federal contract value in Medtech · null in contracts
  • SharpEyes, LLCSimilar federal contract value in Medtech · null in contracts
  • 2B TECHNOLOGIES, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .